DNTH
Price
$23.67
Change
-$0.03 (-0.13%)
Updated
Feb 21 closing price
Capitalization
700.56M
TRDA
Price
$13.04
Change
-$0.03 (-0.23%)
Updated
Feb 21 closing price
Capitalization
488.14M
18 days until earnings call
Ad is loading...

DNTH vs TRDA

Header iconDNTH vs TRDA Comparison
Open Charts DNTH vs TRDABanner chart's image
Dianthus Therapeutics
Price$23.67
Change-$0.03 (-0.13%)
Volume$304.05K
Capitalization700.56M
Entrada Therapeutics
Price$13.04
Change-$0.03 (-0.23%)
Volume$96.61K
Capitalization488.14M
DNTH vs TRDA Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. TRDA commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and TRDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (DNTH: $23.67 vs. TRDA: $13.04)
Brand notoriety: DNTH and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 125% vs. TRDA: 84%
Market capitalization -- DNTH: $700.56M vs. TRDA: $488.14M
DNTH [@Biotechnology] is valued at $700.56M. TRDA’s [@Biotechnology] market capitalization is $488.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNTH and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 4 bearish.
  • TRDA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both DNTH and TRDA are a good buy in the short-term.

Price Growth

DNTH (@Biotechnology) experienced а -3.35% price change this week, while TRDA (@Biotechnology) price change was -2.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 09, 2023.

TRDA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($701M) has a higher market cap than TRDA($488M). TRDA has higher P/E ratio than DNTH: TRDA (9.06) vs DNTH (3.28). DNTH YTD gains are higher at: 8.716 vs. TRDA (-24.407). TRDA has higher annual earnings (EBITDA): 61.3M vs. DNTH (-82.47M). TRDA has more cash in the bank: 449M vs. DNTH (281M). DNTH has less debt than TRDA: DNTH (311K) vs TRDA (61.3M). TRDA has higher revenues than DNTH: TRDA (215M) vs DNTH (5.37M).
DNTHTRDADNTH / TRDA
Capitalization701M488M144%
EBITDA-82.47M61.3M-135%
Gain YTD8.716-24.407-36%
P/E Ratio3.289.0636%
Revenue5.37M215M2%
Total Cash281M449M63%
Total Debt311K61.3M1%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
68
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHTRDA
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 18 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDCTX10.11N/A
N/A
Rational Equity Armor Fund Instl
SILVX18.39N/A
N/A
SGI US Large Cap Equity I
GCEQX92.74N/A
N/A
Green Century Equity Individual Investor
LAVFX15.78N/A
N/A
Lord Abbett Fundamental Equity F
VSEQX37.52N/A
N/A
Vanguard Strategic Equity Inv

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with TRDA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+1.54%
TRDA - DNTH
40%
Loosely correlated
+0.54%
PRME - DNTH
39%
Loosely correlated
-4.72%
ANNX - DNTH
38%
Loosely correlated
-0.70%
IMNM - DNTH
37%
Loosely correlated
+2.12%
RNA - DNTH
37%
Loosely correlated
+1.97%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with MGTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+0.54%
MGTX - TRDA
46%
Loosely correlated
-0.87%
CRNX - TRDA
45%
Loosely correlated
+0.71%
STRO - TRDA
45%
Loosely correlated
-2.14%
ATXS - TRDA
44%
Loosely correlated
-2.57%
RXRX - TRDA
44%
Loosely correlated
-4.78%
More